Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

Sex: All

Ages: 5 Years – 14 Years

Healthy volunteers: No

Phase: NA

Enrollment: 156

Sponsor: Stanford University

Location: Ohana Center for Child and Adolescent Behavioral Health Monterey California

Summary

This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with a mood and/or anxiety disorder * Have proficiency to participate in psychotherapy in English * Scheduled to begin therapy at one of the study sites * RCADS score \> 65 Exclusion Criteria: \- Comorbid diagnosis of intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidal behaviors requiring immediate hospitalization, substance use disorders, or other physical or mental condition that would prohibit them from engaging in telehealth settings.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07155707). StuddyBuddy aggregates publicly available trial information.